Angiogenesis and heparin mimics.

EXS

Department of Chemical Engineering, University of Pennsylvania, Philadelphia.

Published: August 1992

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-0348-7001-6_18DOI Listing

Publication Analysis

Top Keywords

angiogenesis heparin
4
heparin mimics
4
angiogenesis
1
mimics
1

Similar Publications

Localized COUP-TFII pDNA Delivery Modulates Stem/Progenitor Cell Differentiation to Enhance Endothelialization and Inhibit Calcification of Decellularized Allografts.

Adv Sci (Weinh)

December 2024

State key Laboratory of Medicinal Chemical Biology, Frontiers Science Center for Cell Responses, Key Laboratory of Bioactive Materials (Ministry of Education), College of Life Sciences, Nankai University, Tianjin, 300071, China.

Decellularized allografts have emerged as promising candidates for vascular bypass grafting, owing to their inherent bioactivity and minimal immunogenicity. However, graft failure that results from suboptimal regeneration and pathological remodeling has hindered their clinical adoption. Recent advances in vascular biology highlight the pivotal role of COUP-TFII in orchestrating endothelial identity, angiogenesis, safeguarding against atherosclerosis, and mitigating vascular calcification.

View Article and Find Full Text PDF
Article Synopsis
  • The study examined 33 severe COVID-19 patients who underwent a novel hemoperfusion therapy using the Seraph100 filter, aiming to reduce viral RNA levels and markers of inflammation.
  • Results showed that while the initial levels of SARS-CoV-2 RNA were generally low and did not significantly change post-treatment, five inflammatory protein analytes exhibited notable decreases, indicating some therapeutic effect on inflammation and endothelial damage.
  • The conclusion highlighted that Seraph 100 did not effectively lower viral RNA levels, but it did successfully reduce several inflammatory markers in the blood of these patients.
View Article and Find Full Text PDF

The discovery of endothelial progenitor cells has revolutionized our understanding of postnatal blood vessel formation, with endothelial colony-forming cells (ECFCs) emerging as key players in vasculogenesis. Among various ECFC sources, cord blood-derived ECFCs (CB-ECFCs) are of particular interest due to their superior proliferative and clonogenic potential and their ability to promote vascular network formation. Human embryonic stem cell-derived endothelial cells (hESC-ECs) have also shown potential in regenerative medicine, though their vasculogenic efficacy remains unclear compared to CB- and adult blood-derived ECFCs (AB-ECFCs).

View Article and Find Full Text PDF
Article Synopsis
  • Bioengineered livers are being studied as alternatives to traditional liver transplants, addressing donor shortages, but they face issues like thrombosis due to incomplete endothelial layers.
  • This study focuses on applying heparin to decellularized liver scaffolds to improve blood compatibility, cell adhesion, and new blood vessel formation.
  • Results showed that heparin not only reduced blood clotting and increased cell attachment but also significantly enhanced the growth of blood vessels in the scaffolds when tested in mice.
View Article and Find Full Text PDF

A catalytic ROS-scavenging hydrogel (HGel) was developed to enhance the growth factor secretion and the therapeutic efficacy of human adipose-derived stem cells (hADSCs) in inflammatory environments. The HGel is composed of heparin and hyaluronic acid, further functionalized with hemin to endow superoxide dismutase and catalase activities. The functionalization of hemin enables the HGel to effectively scavenge ROS (superoxide and HO), thereby protecting encapsulated hADSCs from oxidative stress and maintaining their metabolic activities.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!